SCHEMBL23844006

SCHEMBL23844006

CO[C@@H](C)COC(=O)[C@H](C)N[PH](=O)OC[C@@](CF)(OC)[C@@H](O)Cc1ccc2c(N)ncnn12

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23844009 0.81 BTN3A1 (0.34) —
SCHEMBL23843960 0.77 RIPK1 (0.33) —
SCHEMBL27439514 0.77 RIPK1 (0.31) —
SCHEMBL23844132 0.76 — —
SCHEMBL23844091 0.75 — —
SCHEMBL23844005 0.74 RIPK1 (0.31) —
SCHEMBL23819057 0.73 RIPK1 (0.30) —
SCHEMBL23844037 0.73 RIPK1 (0.31) —
SCHEMBL27440299 0.72 BTN3A1 (0.33) —
SCHEMBL25012634 0.71 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210292348-A1 ANTIVIRAL COMPOUNDS GILEAD SCIENCES, INC. 2021-09-23 — — US disclosed
Send feedback